Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8214905 | International Journal of Radiation Oncology*Biology*Physics | 2016 | 9 Pages |
Abstract
Dose-intensified, hyperfractionated PT with or without concurrent chemotherapy results in excellent LC after gross total resection, and results in patients with gross disease are encouraging. Patients with high-grade histology are at greater risk of death from distant dissemination. Continuous LC is a major determinant of survival justifying aggressive local therapy in nearly all cases.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Roi MD, MS, Curtis MD, Zuofeng DSc, Daniel PhD, Jeb MD, Peter MD, John MD, Rui MD, DMD, Phil MD, DDS, Donald C. MD, Christopher G. MS, William M. MD,